Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Herzon Lab Resource Report Resource Website |
Herzon Lab (RRID:SCR_008850) | Herzon Lab | access service resource, core facility, service resource | My laboratory has created a family of natural product-inspired anticancer agents. We have evaluated our compounds at the Yale Center for Chemical Genomics, and they are exhibiting IC50 values in the low nM range against K562, HeLa, LnCAP, and HCT-116 lines. Their mechanism of action is unknown, although the natural products have been shown to cleave DNA. An evaluation of the natural products at the NCI has shown that they have a toxicity profile that is distinct from other known DNA damaging agents. We can readily access gram-quantities of these agents for further studies. We are looking for researchers who might find these compounds useful in medicinal applications, for example, for treatment of a specific cancer. We are capable of synthesizing new analogs, such as those incorporating a specific recognition or targeting element, and would be excited to pursue this avenue of research. | chemistry, synthetic anticancer agent, anticancer agent | has parent organization: Yale University; Connecticut; USA | Cancer | nlx_149076 | SCR_008850 | Herzon Laboratory | 2026-08-29 11:32:11 | 0 | |||||||
|
Terry Fox Foundation Resource Report Resource Website 1+ mentions |
Terry Fox Foundation (RRID:SCR_005873) | TFF | institution | The Terry Fox Foundation is responsible for supporting close to $20 million in discovery based research each year in Canada - all monies raised outside Canada must be distributed to (a) an institute approved by the Foundation and its advisors or (b) remitted to Canada. The Terry Fox Research Institute (TFRI) is a recipient of TFF funding for translational research. TFRI is an exciting new initiative whose goal is to translate rapidly today''s best science into better cancer treatment and diagnosis for all Canadians. The Institute will bring scientists and clinicians together across the country into a functionally integrated, geographically dispersed Institute with nodes in several provinces. Terry Fox was diagnosed with osteogenic sarcoma (bone cancer) in his right leg in 1977 and had his leg amputated 15 cm (six inches) above the knee. While in hospital, Terry was so overcome by the suffering of other cancer patients that he decided to run across Canada to raise money for cancer research. He called his journey the Marathon of Hope. Terry''s Marathon of Hope took place in 1980 with the simple objective of informing Canadians of the importance of finding a cure for cancer. With fierce determination, he ran an average of 42 kilometres (26 miles) every day for 143 days. Terry was forced to end his run on September 1, 1980 when the cancer spread to his lungs. By February 1, 1981, Terry''s dream of raising $1 for every Canadian was realized - the Terry Fox Marathon of Hope fund totaled $24.17 million. Terry died in June 1981. On May 26, 1988, The Terry Fox Run became a Trust, independent from the Canadian Cancer Society, and received tax-exempt charitable registration as a public foundation. In addition to our signature and long-standing National Terry Fox Run Day in September of each year, The Terry Fox Foundation is proud to include in its events portfolio The National School Run Day. The Foundation recognizes the duality of its mandate. Not only does it raise money for research, but it also continues to share the story of Terry Fox. The Terry Fox Foundation strives to maintain the heroic effort and integrity that Terry embodied. It is a grassroots organization that does not allow the Terry Fox name or likeness to be commercialized or conjoined with other worthy causes. To date, over $600 million has been raised worldwide for cancer research in Terry''s name. | research, cancer | is parent organization of: Terry Fox Research Institute | Cancer | ISNI: 0000 0004 5907 4557, Crossref funder ID: 501100002655, nlx_149429, grid.453650.1 | https://ror.org/05vd00053 | SCR_005873 | 2026-08-29 11:22:30 | 5 | |||||||
|
Research Accelerator Resource Report Resource Website 1+ mentions |
Research Accelerator (RRID:SCR_006051) | UCSD Research Accelerator | community building portal, data or information resource, database, portal, service resource | Software platform that allows researchers to easily collaborate on research and share reagents, antibodies, cell lines and more. It is designed to increase scientific collaboration across disciplines and geographical boundaries. Among the institutions now using the platform include Yale University, U of Pennsylvania, U of Chicago, Washington U, Cambridge University, University College London. The platform is licensed to select institutions. ResearchAccelerator.org allows researchers to form targeted, data driven collaborations. Researchers can search for data based on gene, disease and pathway, and they can post data which would otherwise be orphaned. The resulting collaborations, which are likely to be transdisciplinary, can greatly amplify impact and research productivity. | collaboration, transdisciplinary research, gene, pathway, disease, cell line, data, human sample, laboratory protocol, medical device, equipment, resource, reagent, research project, transgenic animal, knock out animal, validated antibody, yale keck proteomics assay, allergy, immunology, bone, joint, orthopedic, cancer, cardiovascular, gastroenterology, infectious disease, neurologic disease, organ transplantation, psychiatric disease, reproductive disease, vascular disease, sharing, material resource |
is used by: University College London; London; United Kingdom is used by: University of Cambridge; Cambridge; United Kingdom is used by: Washington University in St. Louis; Missouri; USA is used by: University of Chicago; Illinois; USA is used by: University of Pennsylvania; Philadelphia; USA is used by: Yale University; Connecticut; USA has parent organization: University of California at San Diego; California; USA |
Allergy, Immunology, Bone, Joint, Orthopedic, Cancer, Cardiovascular, Gastroenterology, Infectious Disease, Neurologic disease, Organ Transplantation, Psychiatric disease, Reproductive disease, Vascular disease | The community can contribute to this resource | nlx_151451 | SCR_006051 | ResearchAccelerator.org, ResearchAccelerator | 2026-08-29 11:22:32 | 1 | ||||||
|
ACTREC - Advanced Centre for Treatment Research and Education in Cancer Resource Report Resource Website 1+ mentions |
ACTREC - Advanced Centre for Treatment Research and Education in Cancer (RRID:SCR_006021) | ACTREC | institution | The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India. ACTREC comprises of 2 arms - one for basic research and another for clinical research. The basic research building was inaugurated in March 2002 at the new site of ACTREC in Kharghar, Navi Mumbai. In August 2002, the Cancer Research Institute (CRI) shifted in toto from its Parel campus in Mumbai to serve as the basic research arm of ACTREC. The clinical research arm of ACTREC comprising of the Clinical Research Centre (CRC) has become functional from March 2005. ACTREC also has a 50-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research investigations at CRI currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer. | cancer, basic research, clinical research, drug development, therapy, treatment, prevention, research, education | is parent organization of: HIstome: The Histone Infobase | Cancer | Crossref funder ID: 501100007179, ISNI: 0000 0004 1766 7522, grid.410869.2, nlx_151418 | https://ror.org/05b9pgt88 | SCR_006021 | Advanced Centre for Treatment Research and Education in Cancer | 2026-08-29 11:22:29 | 2 | ||||||
|
Longevity Foundation Resource Report Resource Website |
Longevity Foundation (RRID:SCR_006338) | Longevity Foundation | funding resource | Funding resource that supports research into A-T (Ataxia Telangiectasia) and other debilitating, degenerative diseases plaguing human kind, including cancer and neuro-degeneration associated with auto-immunity and aging. Researchers share their findings and collaborate with each other. The research must lead to practical, near-term treatments and cures to receive funds. The researchers have found treatments and cures that are the first of their kind in the world. Over $850,000 in direct research grants have been made. These grants have leveraged over $9 million in research resources contributed by partner institutions. We pay the research institutions for direct costs only. We pay no administrative, indirect, or overhead costs. | grant, research | Degenerative disease, Ataxia Telangiectasia, Neurodegeneration, Autoimmunity, Inflammation, Premature aging, Aging, Cancer | nlx_152041 | SCR_006338 | 2026-08-29 11:22:34 | 0 | |||||||||
|
CGARS Resource Report Resource Website |
CGARS (RRID:SCR_006404) | CGARS | software resource | Software package to dissect random from non-random patterns in copy number data and thereby to assess significantly enriched somatic copy number aberrations (SCNA) across a set of tumor specimens or cell lines. | genome, analysis |
is listed by: OMICtools has parent organization: University of Cologne; Cologne; Germany |
Cancer | PMID:24413525 | GNU General Public License, v3 or later | OMICS_02210 | SCR_006404 | CGARS: Cancer Genome Analysis by Rank Sums, Cancer Genome Analysis by Rank Sums | 2026-08-29 11:22:39 | 0 | |||||
|
Socrates Resource Report Resource Website 50+ mentions |
Socrates (RRID:SCR_006411) | Socrates | software resource | Software for detecting genomic rearrangements in tumors that utilizes only split-read data. It features single nucleotide resolution, high sensitivity, and high specificity in simulated data. It takes advantage of parallelism for efficient use of resources. | genomic rearrangement |
is listed by: OMICtools has parent organization: Walter and Eliza Hall Institute of Medical Research; Victoria; Australia |
Tumor, Cancer | PMID:24389656 | GNU General Public License, v3, Socrates makes use of external libraries that are licensed under, Apache License, v2, MIT License, Acknowledgement requested | OMICS_02200 | SCR_006411 | Socrates: Identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads, SOft Clip re-alignment To idEntify Structural variants, Socrates - SOft Clip re-alignment To idEntify Structural variants | 2026-08-29 11:22:36 | 56 | |||||
|
AbsCN-seq Resource Report Resource Website 1+ mentions |
AbsCN-seq (RRID:SCR_006409) | AbsCN-seq | software resource | Statistical software to estimate tumor purity, ploidy and absolute copy numbers from next generation sequencing data. | r, statistics, purity, ploidy, absolute copy number, next-generation sequencing |
is listed by: OMICtools has parent organization: University of California at San Diego; California; USA |
Tumor, Cancer | PMID:24389661 | Free, Public | OMICS_02202 | SCR_006409 | 2026-08-29 11:22:39 | 7 | ||||||
|
HMS LINCS Database Resource Report Resource Website 10+ mentions |
HMS LINCS Database (RRID:SCR_006454) | LINCS, HMS-LINCS, HMS LINCS | data or information resource, data repository, database, service resource, storage service resource | Database that contains all publicly available HMS LINCS datasets and information for each dataset about experimental reagents and experimental and data analysis protocols. Experimental reagents include small molecule perturbagens, cells, antibodies, and proteins. | tumor, cancer, database, molecular signature, perturbing agent |
is used by: LINCS Information Framework is recommended by: National Library of Medicine is related to: Broad Institute is related to: OME-TIFF Format is related to: HMS LINCS Center has parent organization: Harvard Medical School; Massachusetts; USA is parent organization of: LINCS Connectivity Map |
Cancer, Diseased joint, Autoimmune disease | NHGRI U54 HG006097; NIH Common Fund |
Available to the research community | nlx_156062, r3d100011833 | http://lincs.hms.harvard.edu/, https://doi.org/10.17616/R3ZK9R | SCR_006454 | NIH LINCS Program, NIH LINCS, Harvard Medical School LINCS Database, LINCS Program, Library of Integrated Network-based Cellular Signatures | 2026-08-29 11:22:37 | 15 | ||||
|
Congressionally Directed Medical Research Program Resource Report Resource Website 50+ mentions |
Congressionally Directed Medical Research Program (RRID:SCR_006456) | CDMRP | nonprofit organization | Fund the best research to eradicate diseases and support the warfighter to benefit the American Public. They promote innovative research, recognizing untapped opportunities, creating partnerships, and guarding the public trust. Research Program topics include: * Amyotrophic Lateral Sclerosis * Autism * Bone Marrow Failure * Breast Cancer * Defense Medical Research and Development Program * Duchenne Muscular Dystrophy * Gulf War Illness * Lung Cancer * Multiple Sclerosis * Neurofibromatosis * Ovarian Cancer * Peer Reviewed Cancer * Peer Reviewed Medical * Peer Reviewed Orthopaedic * Prostate Cancer * Psychological Health / Traumatic Brain Injury * Spinal Cord Injury * Tuberous Sclerosis Complex | grant, funding, one mind tbi, one mind ptsd, medical, medical research, psychological health, orthopedic, peer review, biomedical |
is related to: NIDDK Information Network (dkNET) has parent organization: U.S. Department of Defense |
Amyotrophic Lateral Sclerosis, Autism, Bone marrow failure, Breast cancer, Duchenne muscular dystrophy, Gulf War Illness, Lung cancer, Multiple Sclerosis, Neurofibromatosis, Ovarian cancer, Cancer, Prostate cancer, Traumatic brain injury, Spinal cord injury, Tuberous sclerosis complex | United States Department of Defense | nif-0000-00443, grid.496791.4, Crossref funder ID: 100000090, ISNI: 0000 0000 9367 6288, Wikidata: Q45134126 | https://ror.org/03g2zjp07 | SCR_006456 | DOD CDMRP | 2026-08-29 11:22:40 | 53 | |||||
|
CHASM/SNV-Box Resource Report Resource Website 1+ mentions |
CHASM/SNV-Box (RRID:SCR_006445) | CHASM/SNV-Box | data or information resource, database, software resource | CHASM is a method that predicts the functional significance of somatic missense mutations observed in the genomes of cancer cells, allowing mutations to be prioritized in subsequent functional studies, based on the probability that they give the cells a selective survival advantage. SNV-Box is a database of pre-computed features of all possible amino acid substitutions at every position of the annotated human exome. Users can rapidly retrieve features for a given protein amino acid substitution for use in machine learning. | is listed by: OMICtools | Cancer | NCI CA152432; NCI CA135866; NSF DBI0845275 |
Acknowledgement requested, Free, Non-commercial | OMICS_00127 | SCR_006445 | CHASM / SNV-Box, Cancer-specific High-throughput Annotation of Somatic Mutations | 2026-08-29 11:22:40 | 3 | ||||||
|
DGIdb Resource Report Resource Website 100+ mentions |
DGIdb (RRID:SCR_006608) | DGIdb | application programming interface, data access protocol, data or information resource, database, software resource | A database of drug-gene relationships that provides drug-gene interactions and potential druggability data given list of genes. There are about 15 data sources that are being aggregated by DGIdb, with update date and these data sources are listed on this page: http://dgidb.genome.wustl.edu/sources, THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | drug, gene, interaction, bio.tools, FASEB list |
is listed by: OMICtools is listed by: bio.tools is listed by: Debian has parent organization: Washington University in St. Louis; Missouri; USA |
Cancer | NHGRI U54 HG003079 | PMID:24122041 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_155686, biotools:DGIdb, OMICS_01579 | https://bio.tools/DGIdb | SCR_006608 | Drug-Gene Interaction database, Drug Gene Interaction Database | 2026-08-29 11:22:40 | 408 | |||
|
wikiCancer Resource Report Resource Website 1+ mentions |
wikiCancer (RRID:SCR_001824) | wikiCancer | data or information resource, disease-related portal, patient-support portal, portal, topical portal | A place where people connected to cancer can share real-life experiences -- fears, insights, stories, and advice. Adding perspectives is easy, and every contribution builds the site into a more valuable and unique community resource. Content, resources, and support on wikiCancer: * Just been diagnosed with cancer? * Living with cancer * For cancer survivors * How to support someone with cancer * Connect with other cancer patients, survivors, family and caregivers | wiki | Cancer | Free, Freely available | nlx_15428 | SCR_001824 | 2026-08-29 11:21:04 | 2 | ||||||||
|
ChemoCentryx Resource Report Resource Website 10+ mentions |
ChemoCentryx (RRID:SCR_003976) | commercial organization | A biopharmaceutical company focused exclusively on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Each drug candidate is a small molecule designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inflammatory response driven by that particular chemokine while leaving the rest of the immune system unaffected., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biopharmaceutical, oral administration, medicine, small molecule, chemokine, chemo-attractant receptor, clinical, drug, oral drug | is related to: Kidney Health Initiative | Autoimmune disease, Inflammatory disorder, Cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158383, grid.452218.8, ISNI: 0000 0004 0408 7502 | https://ror.org/04gp12571 | SCR_003976 | ChemoCentryx Inc, ChemoCentryx Inc. | 2026-08-29 11:22:02 | 43 | ||||||
|
C. R. Bard Resource Report Resource Website 1+ mentions |
C. R. Bard (RRID:SCR_003975) | BARD, BCR | commercial organization | A multinational developer, manufacturer, and marketer of medical technologies specializing in the manufacture of vascular, urology, oncology and surgical specialty products. BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs. Bard is perhaps best known for having introduced the Foley catheter. (Adapted from Wikipedia) | medical equipment, vascular, urology, oncology, surgical, medical technology, medical, clinical | is related to: Kidney Health Initiative | Cancer | nlx_158382 | SCR_003975 | C. R. Bard Inc., C.R. Bard Inc., C. R. Bard Inc, CR Bard, C.R. Bard Inc, C.R. Bard, CR Bard Inc. | 2026-08-29 11:21:50 | 2 | |||||||
|
Centre for Genomics and Oncological Research Resource Report Resource Website |
Centre for Genomics and Oncological Research (RRID:SCR_003920) | GENYO | institution | Center for excellence research in genomic medicine, focusing on the comprehensive study and understanding of the genetic basis of human diseases in general, placing special emphasis on cancer and its genetic disorders related to inheritance. GENYO was created as a multidisciplinary research space, where different professionals from the healthcare, university and business areas interact, making it possible to generate new systems to diagnose, prevent and treat diseases based on the joint and coordinated application of first-rate knowledge in the different areas of genetics. The center is the benchmark center of the Andalusian Program for Research in Clinical Genetics and Genomic Medicine, a program which, together with those of Cell Therapy and Regenerative Medicine, and Nanomedicine have the main objective of supporting and fostering translational research in Advanced Therapies. The activities performed within these three research programs are developed in coordination with the Andalusian Initiative for Advanced Therapies (IATA), an initiative of the Andalusian Government promoted by the Regional Ministries of Health and Innovation, Science and Enterprise. | genomic medicine, genomic, oncology, pharmacogenomics, inheritance, genetics |
is related to: PRECISESADS has parent organization: University of Granada; Granada; Spain has parent organization: Progress and Health Foundation; Seville; Spain is parent organization of: PRECISESADS |
Cancer, Genetic disorder | grid.470860.d, Crossref funder ID: 501100007321, ISNI: 0000 0004 4677 7069, nlx_158281 | https://ror.org/04hr99439 | SCR_003920 | Pfizer-University of Granada-Junta de Andaluc??a Centre for Genomics and Oncological Research (GENYO), Pfizer-University of Granada-Junta de Andaluc??a Centre for Genomics and Oncological Research | 2026-08-29 11:21:42 | 0 | ||||||
|
Institute of Cancer Research Resource Report Resource Website 10+ mentions |
Institute of Cancer Research (RRID:SCR_003912) | ICR | institution | Academic cancer research center, a postgrad college, and a charity in the United Kingdom that is making discoveries that defeat cancer. With their partners The Royal Marsden NHS Foundation Trust they form the largest comprehensive cancer center in Europe and perform high quality and original basic research and translational studies, with the aim of developing better treatments for the benefit of cancer patients worldwide. The ICR offers comprehensive, modern facilities for research and studentships supported by the Wellcome Trust, MRC, CRUK and EPSRC and the ICR''s own resources which are awarded on a competitive basis. The ICR offers postgraduate research degrees (MPhil, PhD and MD (Res)) and a modular postgraduate taught degree in oncology aimed at clinicians undertaking specialist training in the field of Clinical or Medical Oncology leading to a Postgraduate Certificate, Postgraduate Diploma or MSc in Oncology. | clinical, medical, oncology |
is related to: PREDECT has parent organization: University of London; London; United Kingdom is parent organization of: FLIGHT is parent organization of: MoKCa- Mutations of Kinases in Cancer |
Cancer | nlx_158259, grid.18886.3f, Wikidata: Q6039999, ISNI: 0000 0001 1271 4623 | https://ror.org/043jzw605 | SCR_003912 | The Institute of Cancer Research | 2026-08-29 11:21:42 | 12 | ||||||
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-08-29 11:22:01 | 34 | |||||||
|
Genentech Resource Report Resource Website 1000+ mentions |
Genentech (RRID:SCR_003997) | Genentech | commercial organization | A biotechnology corporation that uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. | drug, genetic, medicine, biotechnology, oncology, immunology, tissue growth, tissue repair, neuroscience, infectious disease, microbiology, medical imaging |
is related to: Alzheimers Disease Genetics Consortium has parent organization: Roche is parent organization of: GMAP |
Infectious disease, Cancer | nlx_158417 | SCR_003997 | Genentech Inc, F. Hoffmann-La Roche Ltd / Genentech | 2026-08-29 11:21:51 | 3311 | |||||||
|
Eisai Resource Report Resource Website 10+ mentions |
Eisai (RRID:SCR_003936) | Eisai | commercial organization | A global pharmaceutical company. | pharmaceutical, healthcare, drug, oncology, central nervous system, neurology, medicine | is related to: PharmaCog | Cancer, Epilepsy, Alzheimer's disease, Obesity, Immune-mediated disease, Insomnia | grid.418767.b, Wikidata: Q29123933, nlx_158312, ISNI: 0000 0004 0599 8842 | https://ror.org/0469x1750 | SCR_003936 | Eisai Co. Ltd., EISAI Ltd | 2026-08-29 11:21:42 | 17 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
